To gain more understanding about the mechanisms by which CLDN16 mutations can induce FHHNC, we performed an in-depth computational analysis of the CLDN16 gene and protein, focusing specifically on the prediction of the latter’s subcellular localization. The gene discussed is CLDN16; the disease is familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.